Article Details
Retrieved on: 2025-04-28 20:05:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Nurix Therapeutics' use of software development and AI in biotechnology, particularly in drug discovery and design. Their DEL-AI platform accelerates medicinal chemistry processes, identifying binders for drug targets, including IRAK4, in San Francisco.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here